The Global Asthma Spacers Market to Exhibit Moderate Growth
New York , Feb. 16, 2023 (GLOBE NEWSWIRE) -- The Global Asthma Spacers Market to Exhibit Moderate Growth at a CAGR of ~6% by 2027 | DelveInsight
The asthma spacers market is experiencing positive market growth as a result of factors such as the rising prevalence of various respiratory disorders such as asthma, COPD, bronchitis, lung cancer, and others. Furthermore, the growing geriatric population and increased exposure to dust, fumes, airborne chemicals, smoking, and other pollutants will also drive the asthma spacers market in the given forecast period.
DelveInsight’s Asthma Spacers Market Insights report provides the current and forecast market analysis, individual leading asthma spacers companies’ market shares, challenges, asthma spacers market drivers, barriers, and trends, and key asthma spacers companies in the market.
Key Takeaways from the Asthma Spacers Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global asthma spacers market during the forecast period.
- Notable asthma spacers companies such as PARI GmbH, Koninklijke Philips N.V., HAAG-STREIT GROUP, Cipla Inc., Trudell Medical International, Monaghan, Laboratoire ProtecSom, Koo Medical Equipment., AGPMED, Rossmax International Ltd., Teleflex, GSK Plc., Lupin Pharmaceuticals, Inc., Air Liquide Healthcare, GaleMed Corporation., SunMed, ARMSTRONG MEDICAL, DTF Medical, Visiomed, Allergan, Inc., and several others are currently operating in the asthma spacers market.
- In January 2022, Monaghan Medical Corporation (MMC), a pioneer in the development, manufacture, and marketing of respiratory devices such as the AeroChamber Plus, Flow-Vu VHC, AeroEclipse II Nebulizer, and Aerobika Oscillatory Pep Device, received the 2021 Zenith Award from the American Association for Respiratory Care (AARC).
To read more about the latest highlights related to the asthma spacers market, get a snapshot of the key highlights entailed in the Global Asthma Spacers Market Report
Asthma Spacers Overview
Asthma spacers, also known as inhalation chambers, are the external device that improves drug delivery by increasing inhalation and actuation. When used in conjunction with a metered dose inhaler, spacers aid in administering the correct amount of medication to the lungs. Asthma spacers help to reduce medicine waste and the occurrence of dose-related side effects.
Asthma spacers are tube-shaped devices that are attached to inhalers and aid in the administration of medication to asthma patients. The spacer aids in delivering the correct amount of medication to the lungs. Additionally, the use of spacers aids in the avoidance of medication side effects. As a result, asthma spacers are in high demand for asthma management.
Asthma Spacers Market Insights
North America dominated the global asthma spacers market in 2021 and will continue to do so during the forecast period of 2022–2027. This can be attributed to the rising prevalence of asthma and other respiratory disorders in the region, as well as increased exposure to smoking, dust, and fumes, all of which act as supportive factors for the growth of the North American asthma spacers market. Furthermore, the increasing ease of access to modern devices, the presence of key regional players, rising healthcare expenditure, and other factors will drive the asthma spacer market in the coming years. As a result, the interaction of the factors mentioned above would provide a favorable growth environment in the asthma spacers market for the North American region.
To know more about why North America is leading the market growth in the asthma spacers market, get a snapshot of the Asthma Spacers Market Outlook
Asthma Spacers Market Dynamics
The rising prevalence of various respiratory disorders such as asthma, COPD, tuberculosis, and others globally is one of the key factors driving the asthma spacers market. Furthermore, rising cases of pneumonia, a type of acute respiratory infection affecting the lungs, are influencing the growth of the asthma spacers market. Moreover, the growing geriatric population, which is predisposed to the development of respiratory disorders, will increase demand for asthma spacers during the forecast period.
However, the device’s high cost, a lack of professional guidance to patients and practitioners regarding the product or device usage, and other factors may pose challenges to the asthma spacers market growth.
Additionally, the COVID-19 pandemic had a moderate impact on the asthma spacers market growth during the first few months due to lockdown impositions, border closures, and other factors causing disruption in the asthma spacers market’s manufacturing, supply, import, export, and other related activities. During the latter half of the pandemic, however, the asthma spacer market began to recover due to the resumption of activities across industries, including the healthcare sector.
Furthermore, the asthma spacers market saw an increase in product demand as the number of cases of COVID-19 infection increased. Asthma spacers were used in conjunction with respiratory inhalers to treat chest congestion in COVID-19 patients, ultimately increasing demand. Thus, the aforementioned factors increased demand for asthma spacers during the pandemic and are expected to do so again in the forecast period of 2022–2027.
Get a sneak peek at the asthma spacers market dynamics @ Asthma Spacers Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2019–2027 |
| Base Year | 2021 |
| Asthma Spacers Market CAGR | ~6% |
| Projected Asthma Spacers Market Size by 2027 | USD 1.90 Billion |
| Key Asthma Spacers Companies | PARI GmbH, Koninklijke Philips N.V., HAAG-STREIT GROUP, Cipla Inc., Trudell Medical International, Monaghan, Laboratoire ProtecSom, Koo Medical Equipment., AGPMED, Rossmax International Ltd., Teleflex, GSK Plc., Lupin Pharmaceuticals, Inc., Air Liquide Healthcare, GaleMed Corporation., SunMed, ARMSTRONG MEDICAL, DTF Medical, Visiomed, Allergan, Inc., among others |
Asthma Spacers Market Assessment
- Asthma Spacers Market Segmentation
- Market Segmentation By Product Type: Aerochamber, Optichamber, Volumatic, and Inspirease
- Market Segmentation By Distribution Channel: Hospital & Retail Pharmacy, E-Commerce, and Others
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the asthma spacers market are set to emerge as the trendsetter explore @ Asthma Spacers Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Asthma Spacers Market |
| 7 | Asthma Spacers Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Asthma Spacers Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the asthma spacers market by 2027? Click to get a snapshot of the Asthma Spacers Market Trends
Related Reports
Severe Asthma Market
Severe Asthma Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key severe asthma companies, including AstraZeneca, Novartis, Sanofi, among others.
Asthma Pipeline
Asthma Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products, and the key asthma companies, including GSK, AstraZeneca, Teva Pharmaceuticals, among others.
Severe Asthma Pipeline
Severe Asthma Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products, and the key severe asthma companies, including AstraZeneca, Novartis, Sanofi, among others.
Chronic Obstructive Pulmonary Disease Epidemiology Forecast
Chronic Obstructive Pulmonary Disease Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the chronic obstructive pulmonary disease epidemiology trends.
Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, market share of the individual therapies, and key chronic obstructive pulmonary disease companies, including Sanofi, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Verona Pharma, among others.
Acute Respiratory Distress Syndrome Pipeline
Acute Respiratory Distress Syndrome Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, including clinical and non-clinical stage products, and the key acute respiratory distress syndrome companies, including Bayer, Faron Pharmaceuticals, BioMarck Pharmaceuticals, among others.
Other Trending Reports
Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market
Related Healthcare Blogs
Emerging Therapies for Severe Asthma Treatment
COPD Treatment Market
COPD Epidemiological Trends
Chronic Respiratory Disease Market
Promising Therapies in the ARDS Market
Rising Acute Respiratory Distress Syndrome Prevalence
ARDS Market Outlook
Related Healthcare Services
Healthcare Consulting
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
